Literature DB >> 30847998

Perinatal deaths after sildenafil treatment of fetal growth restriction raise the issue of safety in randomised clinical trials.

Niccolò Lombardi1, Giada Crescioli1, Alessandra Bettiol1, Claudia Ravaldi2, Alfredo Vannacci1,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30847998     DOI: 10.1002/pds.4740

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


× No keyword cloud information.
  3 in total

Review 1.  Estrogen Receptors and Estrogen-Induced Uterine Vasodilation in Pregnancy.

Authors:  Jin Bai; Qian-Rong Qi; Yan Li; Robert Day; Josh Makhoul; Ronald R Magness; Dong-Bao Chen
Journal:  Int J Mol Sci       Date:  2020-06-18       Impact factor: 5.923

Review 2.  Estrogen-Induced Uterine Vasodilation in Pregnancy and Preeclampsia.

Authors:  Yan Li; Baoshi Han; Alejandra Garcia Salmeron; Jin Bai; Dong-Bao Chen
Journal:  Matern Fetal Med       Date:  2021-12-09

Review 3.  Sildenafil during the 2nd and 3rd Trimester of Pregnancy: Trials and Tribulations.

Authors:  Felix Rafael De Bie; David Basurto; Sailesh Kumar; Jan Deprest; Francesca Maria Russo
Journal:  Int J Environ Res Public Health       Date:  2022-09-06       Impact factor: 4.614

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.